Active Ingredient(s): Goserelin
FDA Approved: * December 29, 1989
Pharm Company: * ASTRAZENECA
Category: Cancer

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".

Zoladex Overview

Goserelin, sold under the brand name Zoladex among others, is a medication which is used to suppress production of the sex hormones (testosterone and estrogen), particularly in the treatment of breast and prostate cancer.[1][2] It is an injectable gonadotropin releasing hormone agonist (GnRH agonist). Structurally, it is a decapeptide. It is the natural GnRH decapeptide with two substitutions to inhibit rapid degradation. Goserelin stimulates the production of ...

Read more Zoladex Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Goserelin

Recent Zoladex Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

  • Implant: 10.8mg, 3.6mg
  • Insert: 10.8mg, 3.6mg
  • Insert, Extended Release: 10.8mg, 3.6mg
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Zoladex: (5 results)

Sorted by National Drug Code
  • 0310-0950 Zoladex 3.6 mg/1 Subcutaneous Implant by Astrazeneca Pharmaceuticals Lp
  • 0310-0951 Zoladex 10.8 mg/1 Subcutaneous Implant by Astrazeneca Pharmaceuticals Lp
  • 50090-2027 Zoladex 3.6 mg Subcutaneous Implant by A-s Medication Solutions
  • 70720-950 Zoladex 3.6 mg Subcutaneous Implant by Tersera Therapeutics LLC
  • 70720-951 Zoladex 10.8 mg Subcutaneous Implant by Tersera Therapeutics LLC

Other drugs which contain Goserelin or a similar ingredient: (1 result)

Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 22 February 2019.

We are committed to your privacy.

Copyright © 2005-2019 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA